Cryopreserved ampule of Human Bone Marrow Mononuclear Cells containing ≥25 million cells
Cryopreserved ampule of Human Bone Marrow Mononuclear Cells containing ≥5 million cells
Bone Marrow CD34+ Cells, ≥2 million cells, cryopreserved, positively selected
Bone Marrow CD34+ Cells, 100,000 cells, cryopreserved, positively selected
Bone Marrow CD34 Cells+, 500,000 cells, cryopreserved, isolated from mononuclear cells using positive immunomagnetic selection
Bone Marrow CD34+ Cells, 300,000 cells, cryopreserved, positively selected
Cryopreserved ampule of Human Peripheral Blood CD14+ Monocytes, positive selection, containing ≥10 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Cryopreserved ampule of Human Peripheral Blood CD14+ Monocytes, positive selection, containing ≥20 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Cryopreserved ampule of Human Peripheral Blood CD14+ Monocytes, positive selection, containing ≥40 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
-
TechSheet - Human Mesenchymal Stem Cell SystemsTechnical Use and Product Information
-
Electroporation eBook with RegMedNetCD-MI286_Electroporation-eBook-RegMedNet_sec.pdf
-
B-ALI Immune-Airway Co-Culture Model: Normal Human Bronchial Epithelial cells and Peripheral Blood Mononuclear Cells - Instructions for useProtocol to culture B-ALI NHBE cells with PBMCs
-
Two Distinct Activation Methods Yield Clinical-Scale Expansion of Peripheral Blood Derived γδ T CellsIn this study, we demonstrate that billions of γδ T cells can be generated from peripheral blood mononuclear cells (PBMCs) with two distinct activation methods, using TheraPEAK® T-VIVO® Medium.
-
Transfection Protocol for Human CD34+ Cells - 96-well Shuttle™ DeviceInstructions of use for transfection of human CD34+ cells with the P3 Primary Cell 96-well Nucleofector™ Kit
-
Transfection Protocol for Human CD34+ Cells - HT Nucleofector™ DeviceInstructions of use for transfection of human CD34+ cells with the P3 Primary Cell HT-Nucleofector™ Kit
-
Human Mesenchymal Stem Cells - ImprovedUpgrade Your Path to Better Results
-
Transfection Protocol for Mouse Macrophages (BALB/c) - Nucleofector™ 2 DevicesInstructions of use for transfection of mouse Macrophages (BALB/c) with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
Transfection Protocol for Mouse Macrophages (C57BL/6) - Nucleofector™ 2 DevicesInstructions of use for transfection of mouse Macrophages (C57BL/6) with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
Transfection Protocol for Human CD34+ Cells - 4D-Nucleofector™ DeviceInstructions of use for transfection of human CD34+ cells with the P3 Primary Cell 4D-Nucleofector™ X Kit